CHAMBLFERT - Chambal Fertilizers Ltd. (Daily chart, NSE) - LongCHAMBLFERT - Chambal Fertilizers Ltd. (Daily chart, NSE) - Long Position; short-term swing research idea.
Risk assessment: High {volume & support structure integrity risk}
Risk/Reward ratio ~ 3.41
Current Market Price (CMP) ~ 594
Entry limit ~ 592 on May 27, 2025
1. Target limit ~ 610 (+3.04%; +18 points)
2. Target limit ~ 625 (+5.57%; +33 points)
3. Target limit ~ 650 (+9.80%; +58 points)
Stop order limit ~ 575 (-2.87%; -17 points)
Disclaimer: Investments in securities markets are subject to market risks. All information presented in this group is strictly for reference and personal study purposes only and is not a recommendation and/or a solicitation to act upon under any interpretation of the letter.
LEGEND:
{curly brackets} = observation notes
= important updates
(parentheses) = information details
~ tilde/approximation = variable value
-hyphen = fixed value
Review and plan for 28th May 2025 Nifty future and banknifty future analysis and intraday plan.
Quarterly results.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
----Vinaykumar hiremath, CMT
$1 to $4.58 or +353% upside today $LVWRPOWER ⚡ $1 to $4.58 or +353% upside today 🚀 NYSE:LVWR
Morning Buy with additional messages during the day explaining importance of $2 support for after hours squeeze of shortsellers trapped ✅
NASDAQ:IMNN wasn't far from similar move as well
NYSE:BBAI NASDAQ:SBET and NASDAQ:FAAS had power volume
MICROSOFT Correction ahead of 1st 1D Golden Cross in 2 years?Microsoft (MSFT) is just below the $470 All Time High (ATH) and last technical Resistance, following the remarkable rally on the April 07 2025 bottom.
By the first week of June, it should technically form a 1D Golden Cross, which will be its first in more than 2 years (since March 17 2025). That Golden Cross was formed just after the price pulled-back on the 0.382 - 0.5 Fibonacci retracement Zone, finding support on its 1D MA50 (blue trend-line) and rebounding.
As a result, it is quite possible to see a short-term correction to at least $420 before the 1D Golden Cross restores the bullish sentiment. That previous structure eventually hit the -1.0 Fibonacci extension, before the next 1D MA50 test. We therefore expect to see $630 in 2025 before a 1D MA50 correction again.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
NFLX is looking nastyPositive sentiment at ATH, nobody even dares shorting it, all while being extremely overbought and consumers short on expendable income. I've seen this before.
NFA. TP and SL are not accurate, I just used the short position tool to show direction. I'm in position with 1100p looking to TP around 1065 and 980.
Mara Holdings, Inc. —122 2025 New All-Time HighUltra-bullish with new all-time high in sight, MARA hit the lowest price in April 2025 since November 2023.
Good evening my fellow reader, are you a stock trader?
MARA is preparing for a major rise and this opens up an easy trade. A LONG trade.
Needless to say, a "cryptocurrency mining company" is bullish as the Cryptocurrency market turns bullish. No bull market since 2021 and the chart is perfect for a new all-time high.
The previous bull market lasted 602 days and produced 23,593.92% total growth. This time the growth won't be the same, there is nothing like the first bull market, but it will still be very strong. It is likely that the MARA stock will hit all three targets on this chart (49, 73 and 97) and go beyond.
A new all-time high can be 97 followed by 122. I think these levels can be hit easily as part of the bull market bull run. Months and months of continued growth will produce so much bullish momentum that prices will go off the chart.
Namaste.
OSCR 1W — When the Chart Speaks Before the FundamentalsThe Oscar Health chart is currently forming a textbook cup and handle — a long-term reversal structure that has completed its base and is now breaking out of the consolidation zone. The bullish structure is confirmed through price action, volume, and positioning relative to key moving averages.
The price has broken through the upper boundary of the handle, shaped as a descending wedge. The breakout is accompanied by increased volume — a clear sign of capital rotation out of accumulation. All major moving averages (EMA, MA50, MA200, WMA) are trending upward, and the price is holding above them all, confirming the bullish momentum.
According to Fibonacci extension levels, drawn from the historical low of $1.50 to the peak near $23.26, the first wave target stands at $36.71 (1.618 level), with an extended target at $45.02 (2.0 level).
Structurally, the setup suggests a medium-term scenario pointing from current levels toward the $36–45 range, with the potential to repeat the kind of explosive move seen during the 2023 phase, when the price increased more than sixfold.
On the fundamental side, Oscar Health is actively recovering: in 2024, revenue grew by more than 50%, net losses were cut nearly in half, and the client base continued to expand. The company is strengthening its share in the digital insurance market and gaining support from institutional investors, including Morgan Stanley and Capital Group. The latest quarterly report was positively received.
The breakout is technically clean and fundamentally supported. The immediate pullback zones sit at $14.95 and $13.40. Below that, moving averages may act as control zones for reaction.
LLY: Potential Bounce Play with 20–30% UpsideLooking for a stock that had strong momentum before but has slowed down over the past year? One that’s now trading near the bottom of its consolidation range, with about a 30% drop from recent highs? LLY fits that description pretty well.
Based on its pattern, it looks like there’s a good chance it could bounce back toward $970, offering 20–30% upside in the next six months.
This 3 Step System Will Show You The Trending StockThis is a powerful chart for you to watch.
Because its following the Rocket booster
strategy.
The Rocket booster Strategy has 3 Steps;
1-The price has to be above the 50 EMA
2-The price has to be above the 200 EMA
3-The price should gap up or trend up.
In order for us to know whether the price
will trend up we are using the ADX indicator.
We make sure that the Blue line
Is rising between the Green line
and the Red line .
This confirms the last step of the rocket booster
strategy.Also remember that the NASDAQ is up-trending.
Rocket boost this content to learn more.
Disclaimer;Trading is risky please use a simulation account
for trading before you trade with real money.
Also learn risk management and profit taking strategies.
MetaSo far Meta has been following the analysis very nicely. Price came up just short of the 1.618 extension and the 0.786 retracement fib of A. Since then, it has started to move lower and poked below the target box. We could technically get another poke higher to tag the 1.618 but it isn't required. We do have hidden bearish divergence on MACD as you see MACD made a higher high, but price did not. If we can start to get some overlap lower as well as breach the 1.0 @ $597.17, that will be a good sign that the top is in fact in.
If we have topped, we should be looking to the $420-$320 area for the completion of minor C wave. Minor C should take around 2 months or so to complete if it is to follow the lead of A & B. I feel this is all pretty straight forward so I will leave it at that. Please let me know if you have any questions.
$OKTA Gen AI tailwinds are not materializing as of now!- I'm a seller of NASDAQ:OKTA at $124 . Company was undervalued at 70s but has run so much without tangible materializing Gen AI tailwinds.
- Theoretically, Agentic AI should have been a great tailwind for SSO but it appears that industry is not yet focussed on security aspect of it when it comes to agentic AI.
- Even on application level, companies are struggling with developing orchestration framework and deploying them at Scale.
- Risk/Reward is not suitable for me to stay long. Short or Avoid/sell $OKTA.
- I might change my mind if they prove themselves today May 27, 2025.
MNHLDG CONT TO MARK UPA rare schematic, of Type #1 Accmulation
This is a Power Play
-Since Spring, price soaring high with influx of demand (Green Arrow)
With a Possiblity of Feather's Weight ( Yellow LIne)
-Position initiated @ Spring Board (Red Line)
-Plus with additional Local Spring Type Action
Position intiated as attached
Tight Risk
PURE WYCKOFF
Looking to get into ficoThis may take awhile to play out because i think this correction will be very choppy. But I have alerts/buys setup to but at $1300. Fundamentally and technically this seems like a good area to buy into this high quality business. Green horizontals are my levels of interest, i'd like to see these hold or break and then recover quickly. The 50 month ema has been a good spot to buy historically, that looks to be in play as time progresses.
TATA CHEMICALS Breakout Confirmed - Buy on MomentumEntry Price:
Aggressive Entry: Around CMP (₹900-₹905)
Conservative Entry: On a retest of the breakout zone (₹875-₹885), if the opportunity arises.
Target Price 1 (T1): ₹920
Target Price 2 (T2): ₹945
Stop Loss (SL): ₹865 (Closing basis below the breakout zone and previous support)
AI C3ai Options Ahead of EarningsIf you haven`t bought AI before the previous earnings:
Now analyzing the options chain and the chart patterns of AI C3ai prior to the earnings report this week,
I would consider purchasing the 23.5usd strike price Calls with
an expiration date of 2025-5-30,
for a premium of approximately $1.31.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
BUY Pfizer (PFE) growth by Viagra
Tomorrow, I’m entering a position in Pfizer Inc. (NYSE: PFE)—a globally recognized pharmaceutical giant with strong fundamentals and an attractive technical setup.
Pfizer maintains a solid revenue base, reporting $62.46 billion in total revenue in the last fiscal year. Despite recent fluctuations, its profitability remains intact, with a gross profit of $45.15 billion. The company continues to invest in drug innovation and strategic acquisitions, ensuring long-term growth.
Pfizer is a consistent dividend payer, making it an attractive choice for income-focused investors. Its dividend yield remains competitive, reinforcing its appeal as a long-term hold.
I see strong upside potential — both technically and fundamentally. Now is the perfect time to enter.
NBP LONG TRADENBP is in uptrend since long and trading in an upward channel. Recently it made a scallop and gave a massive breakout, making a high of 99.96. Currently, it is in process of retesting its breakout level to resume the uptrend.
TECHNICAL BUY CALL– NBP
BUY1 : Rs. 92.79
BUY2 : Rs. 91.11
BUY3 : Rs. 89
📈 TP1 : Rs. 99.9
📈 TP2 : Rs. 108
STOP LOSS: BELOW Rs. 85 (Daily Close)
📊 RISK-REWARD: Medium Conviction | 1:2.63
Caution: Close at least 50% position size at TP1 and then trail SL to avoid losing incurred profits in case of unforeseen market conditions.
PLEASE BOOST AND SHARE THE IDEA IF YOU FIND IT HELPFUL.
$NVDA – Earnings Super Bubble?🚨 Nvidia is reporting earnings tomorrow, and the market is waiting with bated breath.
While analysts pile on with hyper-bullish predictions extrapolating the AI super bubble, they seem to ignore one glaring fact:
👉 The last time Nvidia beat earnings, the stock crashed -45% shortly after.
Technical view:
We’re near resistance at the previous post-earnings high.
RSI sits at 63.80, hinting at possible exhaustion.
Volume spikes hint at indecision, not confirmation.
This could be a make or break moment for NASDAQ:NVDA and by extension, the entire Tech sector.